クオリプス (TSE) · Health Technology. hisse senedi canlı fiyat verisi ve teknik analiz görünümü. TSE (Tokyo Borsası) verilerini Alerta Chart üzerinden takip edin.
Veri erişimi kontrol ediliyor...
Cuorips, Inc. engages in the development and commercialization of induced pluripotent stem cells (iPS) derived cardiomyocyte sheets. It handles research, development, manufacture, and sales of cellular and tissue-based products and cell processing products. The firm also offers contract development and manufacturing services and consulting services of cellular and tissue-based products and cell processing products. The company was founded on March 21, 2017 and is headquartered in Tokyo, Japan.
Alerta Chart Pro Terminal ile aynı anda 4 grafiği takip edebilir, derinlik (order book) verilerini görebilir ve 25 aktif alarm kurabilirsiniz.
Ücretsiz Başla